Skip to content

CPAP

Home » Werner Baumann: Bayer is making good progress strategically

Werner Baumann: Bayer is making good progress strategically

  • by
Home-ToCPAP

The Bayer Group is making great progress with the acquisition of Monsanto. “After almost two years of very diligent work, we have received nearly all the crucial approvals. We anticipate being able to close the acquisition of Monsanto in the near future,” said Werner Baumann, Chairman of the Board of Management of Bayer, at the company’s Annual Stockholders’ Meeting held in Bonn, Germany, on Friday. Operationally, Bayer’s sales and earnings in 2017 remained on a par with 2016. To ensure that the company’s stockholders once more participate appropriately in Bayer’s success, it was proposed that the dividend be increased for the eighth time in succession, to 2.80 euros per share from 2.70 euros in the previous year. Baumann sees the company in good shape for the future: “We are optimistic because our products and services can improve people’s lives.”

The Bayer Group is making great progress with the acquisition of Monsanto. “After almost two years of very diligent work, we have received nearly all the crucial approvals. We anticipate being able to close the acquisition of Monsanto in the near future,” said Werner Baumann, Chairman of the Board of Management of Bayer, at the company’s Annual Stockholders’ Meeting held in Bonn, Germany, on Friday. Operationally, Bayer’s sales and earnings in 2017 remained on a par with 2016. To ensure that the company’s stockholders once more participate appropriately in Bayer’s success, it was proposed that the dividend be increased for the eighth time in succession, to 2.80 euros per share from 2.70 euros in the previous year. Baumann sees the company in good shape for the future: “We are optimistic because our products and services can improve people’s lives.”

Sales of the Bayer Group in 2017 rose by 1.5 percent on a currency- and portfolio-adjusted basis (Fx & portfolio adj.; reported: 0.2 percent) to around 35 billion euros. Despite negative currency effects, EBITDA before special items was level year on year at 9.3 billion euros. Core earnings per share advanced by 1.0 percent to 6.74 euros.

Baumann thanked the company’s employees for their effort for the company in the past year: “Their commitment, expertise and dedication are what makes Bayer.”

See full article at Agropages

Loading

Leave a Reply

Your email address will not be published. Required fields are marked *